轻度高苯丙氨酸血症：治疗还是不治疗。
Mild hyperphenylalaninemia: to treat or not to treat.
机构信息
Beatrix Children's Hospital, Groningen, Netherlands.
出版信息
J Inherit Metab Dis. 2011 Jun;34(3):651-6. doi: 10.1007/s10545-011-9283-y. Epub 2011 Feb 24.
Abstract
One of the issues to be resolved in phenylketonuria is whether patients with mild hyperphenylalaninemia need treatment, or in other words, in what patients treatment needs to be started. Do patients need treatment when phenylalanine concentrations in blood are >360 μmol/L or >600 μmol/L? This paper reviews the literature on the outcome of untreated patients with mild hyperphenylalaninemia to try to determine whether outcome is normal. The paper concludes that there is, in fact, only one paper that can be used to answer this question. Therefore, the question is whether we may rely on one paper to draw conclusions or whether more research is necessary to determine whether all patients with phenylalanine concentrations >360 μmol/L or all patients with phenylalanine concentrations >600 μmol/L require treatment.
摘要
苯丙酮尿症需要解决的问题之一是轻度高苯丙氨酸血症患者是否需要治疗，换句话说，就是在什么情况下需要开始治疗。当血液中的苯丙氨酸浓度>360μmol/L 或>600μmol/L 时，患者是否需要治疗？本文综述了未经治疗的轻度高苯丙氨酸血症患者的结局相关文献，试图确定结局是否正常。文章得出的结论是，实际上只有一篇文献可以用来回答这个问题。因此，问题是我们是否可以仅凭一篇文献得出结论，还是需要更多的研究来确定所有苯丙氨酸浓度>360μmol/L 的患者还是所有苯丙氨酸浓度>600μmol/L 的患者都需要治疗。
相似文献
1
Mild hyperphenylalaninemia: to treat or not to treat.轻度高苯丙氨酸血症：治疗还是不治疗。
J Inherit Metab Dis. 2011 Jun;34(3):651-6. doi: 10.1007/s10545-011-9283-y. Epub 2011 Feb 24.
2
Non-PKU mild hyperphenylalaninemia (MHP)--the dilemma.非苯丙酮尿症性轻度高苯丙氨酸血症（MHP）——进退两难。
Mol Genet Metab. 2011 Sep-Oct;104(1-2):23-6. doi: 10.1016/j.ymgme.2011.05.007. Epub 2011 May 14.
3
Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.非苯丙酮尿症高苯丙氨酸血症未经治疗患者的智力、神经及神经心理转归。德国苯丙酮尿症协作研究
Pediatr Res. 1997 Sep;42(3):378-84. doi: 10.1203/00006450-199709000-00020.
4
Phenylalanine hydroxylase deficiency.苯丙氨酸羟化酶缺乏症。
Genet Med. 2011 Aug;13(8):697-707. doi: 10.1097/GIM.0b013e3182141b48.
5
Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.葡萄牙代谢中心对苯丙酮尿症患者的代谢控制：三种不同建议的比较。
Nutrients. 2021 Sep 6;13(9):3118. doi: 10.3390/nu13093118.
6
Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders.患有苯丙酮尿症和轻度高苯丙氨酸血症的家庭中这两种疾病遗传的分子分析。
N Engl J Med. 1986 May 15;314(20):1276-80. doi: 10.1056/NEJM198605153142002.
7
Hyperphenylalaninemia in a premature infant with heterozygosity for phenylketonuria.一名患有苯丙酮尿症杂合子的早产儿的高苯丙氨酸血症。
J Perinat Med. 2004;32(4):383-5. doi: 10.1515/JPM.2004.073.
8
[What disorders suspect following an increase of phenylalanine on newborn screening?].新生儿筛查苯丙氨酸升高后应怀疑哪些疾病？
Ann Biol Clin (Paris). 2014 Mar-Apr;72(2):193-6. doi: 10.1684/abc.2014.0942.
9
Neuropsychological assessment among children and adolescents with phenylketonuria and hyperphenylalaninemia and its relationship with plasma phenylalanine levels.苯丙酮尿症和高苯丙氨酸血症患儿及青少年的神经心理学评估及其与血浆苯丙氨酸水平的关系。
Arch Argent Pediatr. 2017 Jun 1;115(3):267-273. doi: 10.5546/aap.2017.eng.267.
10
50 Years Ago in The Journal of Pediatrics: Variability in the Manifestations of Phenylketonuria/Transient Hyperphenylalaninemia.50年前发表于《儿科学杂志》：苯丙酮尿症/短暂性高苯丙氨酸血症表现的变异性
J Pediatr. 2018 Apr;195:65. doi: 10.1016/j.jpeds.2017.10.001.
引用本文的文献
1
Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century?重温威尔逊和荣格纳：筛查标准是否适用于21世纪？
Int J Neonatal Screen. 2024 Sep 13;10(3):62. doi: 10.3390/ijns10030062.
2
In Silico Structural Protein Evaluation of the Phenylalanine Hydroxylase p.(Tyr77His) Variant Associated with Benign Hyperphenylalaninemia as Identified through Mexican Newborn Screening.通过墨西哥新生儿筛查鉴定出的与良性高苯丙氨酸血症相关的苯丙氨酸羟化酶p.(Tyr77His)变体的计算机结构蛋白评估
Children (Basel). 2023 Nov 28;10(12):1865. doi: 10.3390/children10121865.
3
Food Habits and Lifestyle in Hyperphenylalaninemia Patients: Should These Be Monitored?高苯丙氨酸血症患者的饮食习惯与生活方式：是否应予以监测？
Children (Basel). 2022 Aug 3;9(8):1164. doi: 10.3390/children9081164.
4
Cognitive function in untreated subjects with mild hyperphenylalaninemia: a systematic review.未经治疗的轻度高苯丙氨酸血症患者的认知功能：系统评价。
Neurol Sci. 2022 Sep;43(9):5593-5603. doi: 10.1007/s10072-022-06194-6. Epub 2022 Jun 21.
5
Optical Coherence Tomography to Assess Neurodegeneration in Phenylalanine Hydroxylase Deficiency.光学相干断层扫描评估苯丙氨酸羟化酶缺乏症中的神经退行性变
Front Neurol. 2021 Dec 10;12:780624. doi: 10.3389/fneur.2021.780624. eCollection 2021.
6
Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments.苯丙酮尿症的精神和认知方面：饮食的局限性与新疗法的前景
Front Psychiatry. 2019 Sep 10;10:561. doi: 10.3389/fpsyt.2019.00561. eCollection 2019.
7
Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians' current practices.加拿大儿科苯丙氨酸羟化酶（PAH）缺乏症患者的营养管理：营养师当前实践情况调查。
Orphanet J Rare Dis. 2019 Jan 8;14(1):7. doi: 10.1186/s13023-018-0978-0.
8
The complete European guidelines on phenylketonuria: diagnosis and treatment.《苯丙酮尿症的完整欧洲指南：诊断与治疗》。
Orphanet J Rare Dis. 2017 Oct 12;12(1):162. doi: 10.1186/s13023-017-0685-2.
9
Expectations and values about expanded newborn screening: a public engagement study.关于扩大新生儿筛查的期望与价值观：一项公众参与研究。
Health Expect. 2015 Jun;18(3):419-29. doi: 10.1111/hex.12047. Epub 2013 Feb 1.
10
Achieving the "triple aim" for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework.实现代谢性先天性疾病的“三重目标”：对结果研究的挑战综述及新的基于实践证据框架的提出。
Genet Med. 2013 Jun;15(6):415-22. doi: 10.1038/gim.2012.153. Epub 2012 Dec 6.
本文引用的文献
1
Phenylketonuria.苯丙酮尿症。
Lancet. 2010 Oct 23;376(9750):1417-27. doi: 10.1016/S0140-6736(10)60961-0.
2
A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.苯丙氨酸：酪氨酸比值在早期持续治疗的苯丙酮尿症儿童中的作用的初步研究：旨在确定“安全”水平
Dev Neuropsychol. 2010;35(1):57-65. doi: 10.1080/87565640903325725.
3
Future treatment strategies in phenylketonuria.苯丙酮尿症的未来治疗策略。
Mol Genet Metab. 2010;99 Suppl 1:S90-5. doi: 10.1016/j.ymgme.2009.10.008.
4
Psychosocial issues and outcomes in maternal PKU.母体苯丙酮尿症的心理社会问题及结果。
Mol Genet Metab. 2010;99 Suppl 1:S68-74. doi: 10.1016/j.ymgme.2009.10.014.
5
Management of phenylketonuria in Europe: survey results from 19 countries.欧洲苯丙酮尿症管理：来自 19 个国家的调查结果。
Mol Genet Metab. 2010 Feb;99(2):109-15. doi: 10.1016/j.ymgme.2009.09.005. Epub 2009 Sep 13.
6
PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders.苯丙酮尿症——欧洲各中心的日常诊疗情况如何？来自欧洲苯丙酮尿症及相关疾病学会科学咨询委员会问卷调查的数据。
J Inherit Metab Dis. 2009 Feb;32(1):58-64. doi: 10.1007/s10545-008-0966-y. Epub 2009 Jan 13.
7
Stability of blood phenylalanine levels and IQ in children with phenylketonuria.苯丙酮尿症患儿血液苯丙氨酸水平与智商的稳定性。
Mol Genet Metab. 2008 Sep-Oct;95(1-2):17-20. doi: 10.1016/j.ymgme.2008.06.014. Epub 2008 Aug 13.
8
The truth of treating patients with phenylketonuria after childhood: the need for a new guideline.儿童期后苯丙酮尿症患者的治疗现状：制定新指南的必要性
J Inherit Metab Dis. 2008 Dec;31(6):673-9. doi: 10.1007/s10545-008-0918-6. Epub 2008 Aug 12.
9
Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU).对青少年和青年苯丙酮尿症（PKU）患者的生活质量评估及社会人口学状况描述。
Health Qual Life Outcomes. 2008 Mar 26;6:25. doi: 10.1186/1477-7525-6-25.
10
Total homocysteine, B-vitamins and genetic polymorphisms in patients with classical phenylketonuria.经典型苯丙酮尿症患者的总同型半胱氨酸、B族维生素与基因多态性
Mol Genet Metab. 2008 May;94(1):46-51. doi: 10.1016/j.ymgme.2007.12.001. Epub 2008 Jan 14.
Zotero 插件